Literature DB >> 2495226

Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

C Wolz1, G Kiosz, J W Ogle, M L Vasil, U Schaad, K Botzenhart, G Döring.   

Abstract

To investigate cross-colonization with and persistence of Pseudomonas aeruginosa in cystic fibrosis (CF), 181 isolates from 76 CF patients were typed using a P. aeruginosa-specific DNA probe. Whereas sibling pairs predominantly harboured genotypically identical P. aeruginosa strains, all of the other patients harboured different strains. Seventy-nine per cent (22/31) of the infected CF patients harboured the same strains at the beginning and the end of a summer camp. A change of strains was seen in 10% (3/31) of the patients at the end of the camp. Forty-six per cent (6/13) of the patients who were apparently initially uninfected, acquired P. aeruginosa by the end of the period. Genotyping proved that strain change or acquisition was due to cross-colonization in four of nine cases. Very little P. aeruginosa was isolated from the inanimate environment. Persistence of P. aeruginosa after a temporary loss due to antibiotic therapy was seen in 12/16 paired patient strains before and after antibiotic therapy. Thus, suppression followed a flare-up seemed to occur in these patients rather than eradication and a new infection. When 35 patients were followed over a period of 6 months, 7 (20%) changed the strain in their sputum. Only one of 43 patients harboured two different P. aeruginosa strains simultaneously over a long period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495226      PMCID: PMC2249438          DOI: 10.1017/s0950268800029873

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  24 in total

1.  [Current status of acceleration in Bavaria].

Authors:  D VOGT
Journal:  Arch Kinderheilkd       Date:  1959

Review 2.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

3.  Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.

Authors:  D P Speert; D Lawton; S Damm
Journal:  J Pediatr       Date:  1982-08       Impact factor: 4.406

4.  Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.

Authors:  T W Seale; H Thirkill; M Tarpay; M Flux; O M Rennert
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

5.  Does pseudomonas cross-infection occur between cystic-fibrosis patients.

Authors:  N M Kelly; M X Fitzgerald; E Tempany; C O'Boyle; F R Falkiner; C T Keane
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

6.  Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.

Authors:  T Bergan; N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1975-12

7.  Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families.

Authors:  L R Laraya-Cuasay; K R Cundy; N N Huang
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

8.  Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas.

Authors:  C H Zierdt; R L Williams
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

9.  Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

Authors:  N Høiby; K Rosendal
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

10.  Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  G Döring; H J Obernesser; K Botzenhart; B Flehmig; N Høiby; A Hofmann
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  28 in total

1.  Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.

Authors:  E Bingen; E Denamur; B Picard; P Goullet; N Lambert-Zechovsky; P Foucaud; J Navarro; J Elion
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.

Authors:  A Abdul Wahab; S J Taj-Aldeen; F Hagen; S Diophode; A Saadoon; J F Meis; C H Klaassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-01       Impact factor: 3.267

3.  Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.

Authors:  M Fegan; P Francis; A C Hayward; J A Fuerst
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

Authors:  S W Hla; K P Hui; W C Tan; B Ho
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; J Foster; J S Lam; D P Speert
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

6.  Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets.

Authors:  G Döring; H Bareth; A Gairing; C Wolz; K Botzenhart
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

7.  Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Authors:  U B Schaad; J Wedgwood-Krucko; K Guenin; U Buehlmann; R Kraemer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

8.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.

Authors:  B Tümmler; U Koopmann; D Grothues; H Weissbrodt; G Steinkamp; H von der Hardt
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.